Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up.
Santos J, Palacios R, Lozano F, López M, Gálvez MC, de la Torres J, López-Cortés LF, Ríos MJ, Rivero A; Grupo Andaluz Para el Estudio de las Enfermedades Infecciosas (GAEI). Santos J, et al. Among authors: lozano f. AIDS Res Hum Retroviruses. 2008 Jan;24(1):24-6. doi: 10.1089/aid.2007.0142. AIDS Res Hum Retroviruses. 2008. PMID: 18275344 Free article. Clinical Trial.
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study.
Santos J, Palacios R, López M, Gálvez MC, Lozano F, de la Torre J, Ríos MJ, López-Cortés LF, Rivero A, Torres-Tortosa M; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Santos J, et al. Among authors: lozano f. HIV Clin Trials. 2005 Nov-Dec;6(6):320-8. doi: 10.1310/1XAE-BB0W-QN5R-AJGJ. HIV Clin Trials. 2005. PMID: 16566083 Clinical Trial.
Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART.
Palacios R, Hidalgo C, Ríos MJ, Rivero A, Muñoz L, Lozano F, Gutiérrez-Ravé V, Gálvez MC, del Arco A, Santos J. Palacios R, et al. Among authors: lozano f. Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):399-402. doi: 10.1007/s10096-008-0636-x. Epub 2008 Oct 8. Eur J Clin Microbiol Infect Dis. 2009. PMID: 18841401
Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment.
Mira JA, Lozano F, Santos J, Ramayo E, Terrón A, Palacios R, León EM, Márquez M, Macías J, Fernández-Palacin A, Gómez-Mateos J, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Mira JA, et al. Among authors: lozano f. Antivir Ther. 2004 Aug;9(4):511-7. Antivir Ther. 2004. PMID: 15456082 Clinical Trial.
Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.
Gutiérrez-Valencia A, Viciana P, Palacios R, Ruiz-Valderas R, Lozano F, Terrón A, Rivero A, López-Cortés LF; Sociedad Andaluza de Enfermedades Infecciosas. Gutiérrez-Valencia A, et al. Among authors: lozano f. Ann Intern Med. 2009 Aug 4;151(3):149-56. doi: 10.7326/0003-4819-151-3-200908040-00127. Epub 2009 Jul 6. Ann Intern Med. 2009. PMID: 19581631 Free article. Clinical Trial.
Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114.
Pérez-Hernández IA, Palacios R, Mayorga M, González-Doménech CM, Castaño M, Rivero A, Del Arco A, Lozano F, Santos J. Pérez-Hernández IA, et al. Among authors: lozano f. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19795. doi: 10.7448/IAS.17.4.19795. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397539 Free PMC article.
Lipid Changes in Virologically Suppressed HIV-Infected Patients Switching from any Antiretroviral Therapy to the Emtricitabine/Rilpivirine/Tenofovir Single Tablet: GeSida Study 8114.
Palacios R, Mayorga M, Pérez-Hernández IA, Rivero A, Arco AD, Lozano F, Santos J; GESIDA-8114-LIRA Study Group. Palacios R, et al. Among authors: lozano f. J Int Assoc Provid AIDS Care. 2016 May;15(3):189-93. doi: 10.1177/2325957416629785. Epub 2016 Feb 8. J Int Assoc Provid AIDS Care. 2016. PMID: 26858314 Free article.
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM. Rivero A, et al. Among authors: lozano f. Enferm Infecc Microbiol Clin (Engl Ed). 2018 May;36(5):268-276. doi: 10.1016/j.eimc.2017.04.002. Epub 2017 May 19. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 28532596 English, Spanish.
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).
AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan:. AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan:. Enferm Infecc Microbiol Clin (Engl Ed). 2019 Mar;37(3):195-202. doi: 10.1016/j.eimc.2018.02.010. Epub 2018 Jun 18. Enferm Infecc Microbiol Clin (Engl Ed). 2019. PMID: 29759422 English, Spanish.
549 results